Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 12
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Findling, Robert L Pathak, Sanjeev Earley, Willie R Liu, Sherry and DelBello, Melissa P 2014. Efficacy and Safety of Extended-Release Quetiapine Fumarate in Youth with Bipolar Depression: An 8 Week, Double-Blind, Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology, Vol. 24, Issue. 6, p. 325.


    Findling, Robert L. Pathak, Sanjeev Earley, Willie R. Liu, Sherry and DelBello, Melissa 2013. Safety, Tolerability, and Efficacy of Quetiapine in Youth with Schizophrenia or Bipolar I Disorder: A 26-Week, Open-Label, Continuation Study. Journal of Child and Adolescent Psychopharmacology, Vol. 23, Issue. 7, p. 490.


    Correll, Christoph U Sheridan, Eva M and DelBello, Melissa P 2010. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. Bipolar Disorders, Vol. 12, Issue. 2, p. 116.


    Pavuluri, Mani N Passarotti, Alessandra M Mohammed, Tahseen Carbray, Julie A and Sweeney, John A 2010. Enhanced working and verbal memory after lamotrigine treatment in pediatric bipolar disorder. Bipolar Disorders, Vol. 12, Issue. 2, p. 213.


    Pfeifer, Jonathan C. Kowatch, Robert A. and DelBello, Melissa P. 2010. Pharmacotherapy of Bipolar Disorder in Children and Adolescents. CNS Drugs, Vol. 24, Issue. 7, p. 575.


    Singh, Manpreet K. Ketter, Terence A. and Chang, Kiki D. 2010. Atypical Antipsychotics for Acute Manic and Mixed Episodes in Children and Adolescents with Bipolar Disorder. Drugs, Vol. 70, Issue. 4, p. 433.


    Steinhausen, Hans-Christoph 2010. Psychische Störungen Bei Kindern und Jugendlichen.


    McClure-Tone, Erin B. 2009. Socioemotional Functioning in Bipolar Disorder Versus Typical Development: Behavioral and Neural Differences. Clinical Psychology: Science and Practice, Vol. 16, Issue. 2, p. 98.


    Koelch, Michael Schnoor, Kathleen and Fegert, Joerg M 2008. Ethical issues in psychopharmacology of children and adolescents. Current Opinion in Psychiatry, Vol. 21, Issue. 6, p. 598.


    Waxmonsky, James Pelham, William E. Gnagy, Elizabeth Cummings, Michael R. O'Connor, Briannon Majumdar, Antara Verley, Jessica Hoffman, Martin T. Massetti, Greta A. Burrows-MacLean, Lisa Fabiano, Gregory A. Waschbusch, Daniel A. Chacko, Anil Arnold, Frances W. Walker, Kathryn S. Garefino, Allison C. and Robb, Jessica A. 2008. The Efficacy and Tolerability of Methylphenidate and Behavior Modification in Children with Attention-Deficit/Hyperactivity Disorder and Severe Mood Dysregulation. Journal of Child and Adolescent Psychopharmacology, Vol. 18, Issue. 6, p. 573.


    Christodoulou, George N. and Christodoulou, Nikolaos G. 2007. Early intervention in psychiatry. Early Intervention in Psychiatry, Vol. 1, Issue. 1, p. 7.


    DELBELLO, MELISSA P. CORRELL, CHRISTOPH U. CARLSON, GABRIELLE A. CARLSON, HAROLD E. and KRATOCHVIL, CHRISTOPHER J. 2007. Pharmacological Management of Bipolar Disorder in a Youth With Diabetes. Journal of the American Academy of Child & Adolescent Psychiatry, Vol. 46, Issue. 10, p. 1375.


    ×

Pharmacological interventions for bipolar youth: Developmental considerations

  • MELISSA P. DELBELLO (a1) and ROBERT A. KOWATCH (a1)
  • DOI: http://dx.doi.org/10.1017/S0954579406060597
  • Published online: 01 December 2006
Abstract

Despite the high prevalence rate, there have been relatively few controlled studies to systematically examine pharmacological treatments for children and adolescents with bipolar disorder. We review the differences in clinical characteristics between youth and adults with bipolar disorder and the extant literature of pharmacological treatments for children and adolescents with bipolar disorder, as well as discuss the effectiveness of pharmacological interventions for treating children and adolescents who are at familial risk for developing bipolar disorder. Although the number of controlled studies of youth with manic and mixed episodes is rapidly growing, there are few studies examining treatments for depression and the prevention of recurrent affective episodes in this population. Although children and adolescents with bipolar disorder commonly present with co-occurring psychiatric disorders, such as attention-deficit/hyperactivity disorder, there are limited data to guide the treatment of these patients. Recently, studies have begun to characterize prodromal manifestations of bipolar disorder and identify early intervention strategies for treating children and adolescents with an elevated risk for developing bipolar disorder.

Copyright
Corresponding author
Address correspondence and reprint requests to: Melissa P. DelBello, Division of Bipolar Disorders Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0559; E-mail: delbelmp@email.uc.edu
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Development and Psychopathology
  • ISSN: 0954-5794
  • EISSN: 1469-2198
  • URL: /core/journals/development-and-psychopathology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×